Neurogene (NASDAQ: NGNE), a genetic medicine company, saw its stock skyrocket by 43% on Monday following news of a $200…
Read More »Biotech
Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price…
Read More »
Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in a wide range of leading-edge, proprietary…
Read More »
The ongoing US port strike on the East and Gulf coasts is causing significant disruptions to pharmaceutical supply chains, particularly…
Read More »
Proprietary diagnostic and medical device technologies developer and investment partner Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) announced that…
Read More »
Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with…
Read More »
Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in cutting-edge diagnostic and medical device technologies,…
Read More »
Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a burgeoning name in the medical device industry, has achieved a significant…
Read More »
Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in advanced diagnostic and medical device technologies,…
Read More »
Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as…
Read More »